Suguru Okami is currently the Head of Integrated Evidence Generation Japan at Bayer Pharmaceuticals, a position held since 2021. Previously, Suguru served as the Science Lead in Medical Affairs for Cardiovascular, Renal, and Metabolism at AstraZeneca from 2019 to 2021. Earlier in their career, they were a Medical Affairs Associate at AstraZeneca K.K., focusing on cardiovascular matters from 2013 to 2017. Suguru is pursuing a Doctor of Philosophy (PhD) at Keio University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices